Search clinical trials for: Inhaled alprazolam 1 mg

Total 1254 results

Alexza Pharmaceuticals, Inc.

Completed

Staccato Alprazolam Abuse Liability

Abuse Liability of Staccato Alprazolam

United States
Alexza Pharmaceuticals, Inc.
The Epilepsy Study Consortium

Completed

Staccato Alprazolam and Photoparoxysmal Response

Epilepsy

United States
Alexza Pharmaceuticals, Inc.

Completed

Staccato Alprazolam in Panic Attack

Treatment of Induced Panic Attack

United States
Alexza Pharmaceuticals, Inc.

Completed

Staccato Zaleplon Single Dose Pharmacokinetics

Healthy

United States
Sandoz

Completed

To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 1 mg

Anxiety
Alexza Pharmaceuticals, Inc.

Completed

Staccato Prochlorperazine in Migraine (Out Patient)

Migraine Headache | Aura

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Alprazolam Extended-Release Tablets 1 mg to Xanax XR Tablets 1 mg

Healthy

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Fasting Conditions

Healthy

United States
Alexza Pharmaceuticals, Inc.

Completed

Staccato Loxapine Single Dose PK

Schizophrenia

United States
Alexza Pharmaceuticals, Inc.

Completed

Staccato Loxapine in Agitation (Proof of Concept)

Schizophrenia

United States
Engage Therapeutics, Inc.
Clinilabs, Inc.

Completed

Pharmacokinetic Study Evaluating Staccato® Alprazolam 1 mg Inhaler in Smokers Versus Non-Smokers

Healthy

United States
Alexza Pharmaceuticals, Inc.
PPD

Completed

Staccato Prochlorperazine Single Dose PK Study

Migraine

United States
University of California, San Diego
National Institute of Mental Health (NIMH)

Completed

PharmacofMRI (Functional Magnetic Resonance Imaging) of Anxiolytic Medications (Alprazolam)

Anxiety Disorders

United States
Pearl Therapeutics, Inc.

Completed

Phase I Study Evaluating the Safety and Pharmacokinetics of Budesonide, Glycopyrronium, and Formoterol Fumarate Inhalation Aerosol (BGF MDI) in Healthy Volunteers

Healthy Volunteers

United States
GlaxoSmithKline

Completed

Bioequivalence Trial of Alprazolam 2 mg Tablets

Anxiety Disorders
Liquidia Technologies, Inc.
Nuventra, Inc.

Active, not recruiting

Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of Treprostinil

Primary Pulmonary Hypertension

United States
Alexza Pharmaceuticals, Inc.

Completed

Staccato Loxapine in Agitated Patients With Bipolar Disorder

Bipolar I Disorder

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Non-Fasting Conditions

Healthy

United States
Isfahan University of Medical Sciences

Completed

Alprazolam as Conscious Sedation for Upper Gastrointestinal Endoscopy

Diagnostic Esophagogastroduodenoscopy

Iran, Islamic Republic of
Dartmouth-Hitchcock Medical Center
Novartis Pharmaceuticals

Terminated

Evaluation of Inhaled Antibiotics on Bacterial Diversity and Richness in the Cystic Fibrosis Lung

Cystic Fibrosis

United States
Timothy L. Brown
National Highway Traffic Safety Administration (NHTSA); Cognitive Research... and other collaborators

Completed

Validation of the Drug Impaired Driving Scenario (DIDS) on the CRCDS-miniSim (PDID)

Driving Under the Influence | Driving Behavior

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg

Healthy

United States
GlaxoSmithKline

Completed

Bioequivalence Trial of Alprazolam 0.5 mg Tablets

Anxiety Disorders
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD

Attention Deficit Disorder With Hyperactivity

United States
Alexza Pharmaceuticals, Inc.

Completed

ADASUVE-Lorazepam Drug-Drug Interaction

Healthy Volunteers

United States
Alexza Pharmaceuticals, Inc.

Completed

Staccato Loxapine in Migraine (Out Patient)

Migraine Headache

United States
Mylan Pharmaceuticals Inc

Completed

Fed Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg

Healthy

United States
Alexza Pharmaceuticals, Inc.

Completed

Staccato Loxapine in Agitated Patients With Schizophrenia

Patients With Schizophrenia and Acute Agitation

United States
Groupe Hospitalier de la Region de Mulhouse et...

Completed

Evaluation of the Efficacy of Aromatherapy on the Well-being of Healthcare Professionals (HERBAS)

Healthcare Professionnals

France
Universitair Ziekenhuis Brussel

Unknown

Sedative Premedication in Coronary Angiography

Coronary Angiography | Sedative Premedication

Belgium
Pfizer

Completed

Multiple Oral Doses Of PH-797804 In Healthy Japanese Adult Subjects

Healthy

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Alprazolam 3 mg Extended Release Tablets Under Non-fasting Conditions

Healthy

United States
Central Hospital, Nancy, France

Recruiting

Preoperative Hypnosis Versus Premedication in Gynecological Surgery (HYPNOGYN)

Gynecologic Disease | Anxiety Disease

France
Actavis Inc.

Completed

A Relative Bioavailability Study of Alprazolam 3 mg ER Tablets Under Fasting Conditions

Healthy

United States
United Therapeutics

Withdrawn

Safety and Efficacy of Inhaled Treprostinil in Patients With PAH (INTREPID)

Pulmonary Arterial Hypertension
Johnson & Johnson K.K. Medical Company

Completed

Open-Label Study for Shoulder Dislocation Using MG-1 (MG-1)

Shoulder Dislocation

Japan
GlaxoSmithKline

Completed

Preference Attributes of ELLIPTA Dry Powder Inhaler (DPI) and HANDIHALER DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

United States
Sandoz

Completed

To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 2 mg

Anxiety
Teva Pharmaceuticals USA

Completed

Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Non-fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Fasting Conditions

Healthy

United States
GlaxoSmithKline

Completed

Bioequivalence Trial of Alprazolam 0.25 mg Tablets

Anxiety Disorders
Bio Sidus SA

Completed

PK/PD Study of 2 Agalsidase Formulations in Single Dose of 1 mg/kg Administered to Healthy Volunteers as IV Infusion

Fabry Disease

Argentina
GlaxoSmithKline

Completed

PK Study of IV Formulation of GW856553

Cardiovascular Disease

United Kingdom
United Therapeutics

Terminated

A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD) (PERFECT)

Chronic Obstructive Pulmonary Disease | Pulmonary Hypertension

United States, Israel, Argentina, Puerto Rico
Shanghai Asclepius Meditec Inc.
Guangdong Provincial Hospital of Traditional Chinese Medicine; Henan Provincial... and other collaborators

Unknown

Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19 (COVID-19)

COVID-19

China
Merck Sharp & Dohme LLC

Terminated

Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019) (APECS)

Alzheimer's Disease | Amnestic Mild Cognitive Impairment | Prodromal Alzheimer's Disease
Galderma R&D

Completed

Performance of Different Application Regimens of ACTINICA® on Protection From UVR-induced Erythema After One Day of Sun Exposure in Fair-skinned Healthy Subjects.

Healthy Subjects, Male or Female, of 18-60 Years Old, With Phototype I, II or III, Not Pre-treated/Pre-protected Skin

France
Ain Shams University

Completed

Doubling the Iron Dose to Prevent IDA in Twin Pregnant Women (IDA)

Hematologic Pregnancy Complications

Egypt
Sunovion

Completed

Dasotraline SEP360-105 Pediatric PK/PD Study

Pediatric Attention Deficit Hyperactivity Disorder

United States
Zydus Therapeutics Inc.

Recruiting

Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis (EPICS-III)

Primary Biliary Cholangitis

United States, Argentina, Iceland, Turkey

Search clinical trials for: Inhaled alprazolam 1 mg

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations